IDH1 and neoplasm: One systematic review found that the T2-FLAIR mismatch sign had a sensitivity and specificity of 42% (95%CI: 34–50%), and 99% (95%CI: 96–100%) for detecting IDH-mutant, 1p/19q non-codeleted tumor, respectively [10].